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Abstract
The differentiation and senescence programs of metazoans play key roles in regulating normal development and
preventing aberrant cell proliferation, such as cancer. These programs are intimately associated with both the mitotic and
apoptotic pathways. Caspase-8 is an apical apoptotic initiator that has recently been appreciated to coordinate non-
apoptotic roles in the cell. Most of these functions are attributed to the catalytic domain, however, the amino-terminal
death effector domains (DED)s, which belong to the death domain superfamily of proteins, can also play key roles during
development. Here we describe a novel role for caspase-8 DEDs in regulating cell differentiation and senescence. Caspase-8
DEDs accumulate during terminal differentiation and senescence of epithelial, endothelial and myeloid cells; genetic
deletion or shRNA suppression of caspase-8 disrupts cell differentiation, while re-expression of DEDs rescues this
phenotype. Among caspase-8 deficient neuroblastoma cells, DED expression attenuated tumor growth in vivo and
proliferation in vitro via disruption of mitosis and cytokinesis, resulting in upregulation of p53 and induction of
differentiation markers. These events occur independent of caspase-8 catalytic activity, but require a critical lysine (K156) in
a microtubule-binding motif in the second DED domain. The results demonstrate a new function for the DEDs of caspase-8,
and describe an unexpected mechanism that contributes to cell differentiation and senescence.
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Introduction
Caspase-8 is an initiator protease recruited to the death
inducing signaling complex during apoptosis initiated by death
receptors. Homotypic interactions, mediated by the amino-
terminal death effector domains (DEDs) of caspase-8, are required
for recruitment and subsequent maturation and dimerization of
caspase-8 initiating the extrinsic apoptosis cascade. In addition to
this role in death receptor-mediated apoptosis, cumulative
evidence suggests that caspase-8 performs other non-apoptotic
functions in development [1], including proliferation [2,3], cell
migration [4–7] and differentiation [3,8]. We and others
previously reported that caspase-8 has the capacity to localize to
a number of different cellular locations, including the cytosolic
compartment [9], actin-rich ruffles [10,11], endosomes [12],
including those at the front of migrating cells[13], focal adhesions
[4] and stable microtubule structures, such as centrosomes [14].
Interestingly, the different domains of caspase-8 appear to favor
localization to different cellular compartments. It is possible that
these different preferred locations may ultimately influence
caspase-8 function(s).
Differentiation, senescence, and apoptosis are critical programs
for the development and maintenance of cellular homeostasis.
Disruption of any of these essential processes is an important
component in the pathogenesis of many diseases, including cancer.
A common characteristic of human cancer is disrupted cellular
differentiation [15]. In some cancer cells, the induction of
differentiation with therapeutic agents terminates uncontrolled
proliferation [16,17]. Even among therapies which do not aim to
specifically induce cell differentiation or senescence, it nonetheless
appears to be a common mechanism limiting tumor growth [18].
Therefore, cellular senescence is not only a physiological program
that limits the proliferative capacity of an indiviudal cell, but plays
an important physiological role as a natural barrier to suppress
pathogenic transformation or proliferation [19].
In the current study we observed in epithelial, endothelial,
myeloid and tumor cells, that lack of caspase-8 exhibited a
disrupted pattern of cellular differentiation/senescence. Specifi-
cally, we find that caspase-8 expressing myeloid, endothelial or
epithelial cells display an accumulation of caspase-8 DEDs during
the onset of differentiation and senescence. Silencing of caspase-8
correlates with disruption of differentiation, and increase in
replicative capacity, while expression of the DEDs is sufficient to
promote differentiation and proliferative arrest. In particular,
these events occur independent of caspase catalytic activity, but
require the ability of DEDs to bind to microtubules. The
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7879microtubule interaction capacity of caspase-8 DEDs, in turn,
promotes aberrant mitosis, multinucleation, and induces apoptosis,
senescence or terminal differentiation. Our results support the
notion that caspase-8 is a multifunctional tumor suppressor
protein, demonstrating that the DEDs of caspase-8 act to regulate
not only cell death, but also differentiation and senescence.
Results
Caspase-8 Regulates Terminal Differentiation
Caspase-8 has been shown to play non-apoptotic roles in many
tissues [1,3,20,21]. Caspase-8 is particularly enriched in the skin
[20], with a notable accumulation in the differentiating layers of
the epidermis (Figure 1A, B and Figure S1A and B). Interestingly,
the skin of caspase-8 knockout mice shows clear signs of
hyperproliferation, particularly through the basal and spinous
layers (Figure 1A). Examining the skin of K14
Cre/C8
flox/flox
animals, we found that loss of caspase-8 expression is associated
with a deficient commitment of the basal cells to undergo terminal
differentiation. In addition to epidermal thickening, the keratino-
cyte marker K5 is not restricted to a single cell layer, but rather is
maintained throughout several cell layers (Figure 1A). Moreover,
in caspase-8-deficient animals, the microtubules of the keratino-
cytes remained largely cytosolic rather than peripheral (Figure 1B),
suggesting that the uncoupling of microtubules from the
centrosome, associated with keratinocyte exit from proliferation,
was disrupted [22]. Together, these results indicated that caspase-8
plays an important role in attenuating skin proliferation and/or
modulating skin differentiation.
To examine this further, we next used a keratinocyte model of
induced differentiation [23–25]. Differentiation of HaCat cells did
not induce significant DEVDase (caspase) activity, nor did it
promote accumulation of caspase-8 activation products such as the
cleaved fragment p43 (Figure 1C and data not shown). The level of
pro-caspase-8 expression did not change during this process,
however, we did detect a modest accumulation of the DED
domains among differentiating and non-proliferative cells
(Figure 1C, right). We also detected the DEDs of caspase-8 at
the centrosome, and this persisted during reorganization of the
microtubules upon differentiation (Figure 1C, left).
To evaluate whether the DEDs of caspase-8 influence cell
differentiation, we next examined myeloid differentiation, in which
caspase-8 has been implicated in vivo [3,8]. Phorbol-ester-induced
differentiation of U937 cells resulted in DED accumulation, as
determined via immunoblot analysis with a monoclonal antibody
to the DEDs of caspase-8 (Figure 2A). No caspase-8 DEDs were
observed in differentiated U937 cells in which caspase-8
expression was silenced (U937-shC8) (Figure 2B, inset). Differen-
tiation of the U937-shC8 cells was consistently compromised
relative to control cells expressing caspase-8 (Figure 2B and C),
both, by expression of the macrophage marker CD11b when
scored by flow cytometry (Figure 2B) or by morphological criteria
(Figure 2C). Importantly, re-expression of the DEDs was sufficient
to rescue the differentiation process (Figure 2C). Together, these
results support the notion that the DEDs of caspase-8 regulate
terminal differentiation.
Caspase-8 DED Suppress Tumor Growth
Our observations suggested that the DEDs of caspase-8 were
responsible for influencing terminal differentiation events. Neo-
plasms such as neuroblastoma can arise in part due to the failure of
precursor cells (neuroblasts) to differentiate correctly [19].
Aggressive disease is associated with the loss of caspase-8 [26],
while spontaneously resolving tumors (neuroblastoma type IV-S)
Figure 1. Effects of caspase-8 downregulation in skin matura-
tion. A. Immunohistochemistry analysis performed in skin from
wildtype and caspase-8 knock out mice. Caspase-8 DEDs are stained
in green, keratin 5 in red and nuclei in blue. Brackets denote expanded
epidermis in the caspase-8 knockout mice. B. Microtubule staining (red
channel) in skin from wild type and caspase-8 knockout mice. Insets
show magnified views of the microtubule patterning in wild type and
caspase-8 knockout mice. C. Left, Confocal images of HaCat
undifferentiated and differentiated cells stained for caspase-8 DEDs
(green channel) and microtubules (red channel). Yellow arrows indicate
centrosomes. Right, Immunoblot analysis of caspase-8 expression in
undifferentiated or differentiated keratinocytes. Lysates were probed
with antibody recognizing the DEDs of caspase-8.
doi:10.1371/journal.pone.0007879.g001
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expression of DEDs among cells that already express caspase-8
induces apoptosis among caspase-8 positive cells [14,28]. Many of
these cells express readily detectable levels of DEDs, and appear to
be intolerant to additional expression. Therefore, we next used
caspase-8-deficient neuroblastoma cells to evaluate the role of
caspase-8 DEDs in tumor progression. Interestingly, the growth of
DED-GFP reconstituted neuroblastoma tumors in the chick
chorioallantoic membrane was significantly inhibited relative to
control tumors expressing GFP alone (Figure 3A). Accordingly, we
found that the DED-GFP expressing cells did proliferate
significantly less than control cells expressing GFP (Figure 3B).
Thus, DED expression influenced neuroblastoma proliferation in
vitro and in vivo. The effect did not appear to be related to
’’toxicity‘‘ of DEDs, as the reconstituted neuroblastoma expressed
similar levels of DEDs compared to other cell lines examined
(COS-7, NB16; reference 14).
DED Expression Causes Mitotic Defects
Interestingly, DED association with microtubule-containing
structures can influence cell responses to paclitaxel (14), and thus,
DED association with microtubules might influence cell division
and/or proliferative arrest. The DEDs of caspase-8, but not
c-FLIP, interact with stable microtubule structures (Figure S2),
including centrosomes, spindle poles and midbodies in neuroblas-
toma cells [14] as well as keratinocytes and other epithelial cells
(Figure S3A). Microtubule dynamics play a key role in regulating
normal cell division, therefore, we tested the effect of DED
expression on mitotic progression. Notably, we found an increased
incidence of aberrant mitotic figures in DED-expressing neuro-
blastoma cells (Figure 3C). This was associated with an enrichment
of DED-expressing cells in pre-metaphase relative to GFP-
controls, suggesting mitotic delay (Figure 3D). In post-mitotic
cells, DED-GFP expression was associated with multinucleation
(Figure 3E, F, and Supplementary Figure S3B). Intriguingly, other
cells which exhibit high basal levels of multinucleation, such as
COS-7 [29] also expressed abundant caspase-8 DEDs (Figure
S2C). Thus, the DEDs of caspase-8 influence normal cellular
mitotic function, impacting cell proliferation.
In contrast, the decreased proliferation was not explainable
simply by mitotic defects leading to apoptosis, since faster
proliferation and larger tumors in vivo were derived from cells
expressing a pro-apoptotic (wt) form of caspase-8. This caspase-8
GFP construct exhibited higher levels of apoptosis than the DED-
GFP cells, but nonetheless grew larger in vivo and faster in vitro
(Figure S4C, D and E). These studies also demonstrated that
DEDs expressed as part of an inactive caspase-8 holoprotein
(Casp8*-GFP) showed no deleterious effects on the cell (Figure
S3C and E), possibly due to intra-domain interactions in the native
procaspase. Moreover, DED expression in other caspase-8-
deficient tumors (small cell lung carcinoma) [30], similarly
impacted proliferation and resulted in multinucleation (Figure
S4F), thereby validating the concept that DEDs contribute to
mitotic crisis and cell cycle arrest.
DEDs Activate the p53 Pathway and Induce Apoptosis or
Cell Cycle Arrest
We considered that selection pressure might result in the loss of
caspase-8 DEDs, and increased proliferation and tumor formation
might result with continued passage of the cells. To our surprise,
we observed that proliferation of neuroblastoma cells did not
increase, and that DED-expressing cultures arrested ,30 passages
after initial selection. Beyond early passages (p5–p12), multi-
nucleation was increasingly common among the DED-expressing
Figure 2. Caspase-8 DEDs are required for terminal differen-
tiation of monocytes. A. Images of undifferentiated U937 monocytes
(control) and differentiated macrophages (scale bar=10 mm). Immuno-
blot analysis of caspase-8 expression among U937 undifferentiated
monocytes (control) and differentiated macrophages. Lysates were
probed with antibody recognizing the DEDs of caspase-8, with analysis
of tubulin shown as a loading control. B. Monocytes were induced to
differentiate by treatment with phorbol esters after infection with
lentivirus encoding shRNA to caspase-8 or a control shRNA. Flow
cytometry of control and caspase-8 knockdown U937 cells using CD11b
expression as a reporter of differentiation. DED expression during
differentiation was assessed by immunoblot analysis of these lysates
with an antibody to caspase-8 DED domain (inset). C. Evaluation of
U937 differentiation was performed by direct microscopic assessment
using standard morphological criteria (round undifferentiated and
spread differentiated). Data were analyzed with Fisher’s Exact Test
(*, significant difference, p#0.05).
doi:10.1371/journal.pone.0007879.g002
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exhibited striking changes in phenotype, including elongate
morphology and loss of proliferation (Figure 4A lower panels).
Testing these cells for classical markers of cell cycle arrest [18], we
observed an accumulation of both p21 and p53 in DED-GFP
expressing cells (Figure 4B and Figure S4A, left panel). In
agreement with our previous results in myeloid cells (Figure 2) and
keratinocytes (Figure 1), this induced proliferative arrest that was
accompanied by expression of neuronal differentiation markers
such as MAP2 (Figure 4B) and bIII tubulin (Figure S5A, right
panel). Therefore, the DEDs of caspase-8 appeared to influence
both, multinucleation and the acquisition of cellular differentiation
in the neuroblastoma cell model. To further validate a role of the
DEDs in proliferative arrest, we used primary endothelial cell
cultures, a known model of replicative senescence (Figure S5B and
C). Endothelial cells also accumulated caspase-8 DEDs, and
Figure 3. Caspase-8 DEDs decrease tumor burden, proliferation and induce multinucleation. A. Evaluation of tumor growth in chick
embryos of NB7 neuroblastoma cells stably transfected with DED-GFP or control GFP. Data were analyzed with U-Mann-Whitney Test (*, significant
differences, p#0.05). B. The proliferation capacity of NB7-GFP or NB7 DED-GFP was monitored by direct counting of cells after 24, 48, 72 and 96 hours
in culture after being seeded at 100, 000 cells/ml. C. Representative immunofluorescent images are shown, with alpha tubulin (red channel) and
DNA/chromosomes (blue channel) evident in mitotic cells (scale bar=10 mm). Microscopic quantification of aberrant mitosis. Data were analyzed
with T-student Test (*, significant differences, p#0.05; **, very significant differences, p#0.01). D. Quantification of mitotic cells expressing GFP or
DED-GFP. The distribution of mitotic cells is significantly different in these populations (P=Prophase, PM=Pro-metaphase, M=Metaphase and A/
T=Anaphase/Telophase). Data were analyzed with T-student Test (*, significant differences, p#0.05). E. Confocal microscopy indicating the presence
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Knockdown of caspase-8 did not prevent senescence among the
endothelial cells, but did reduce multinucleation and typically
permitted additional 2–3 passages prior to arrest (Figure S5C).
Together, the results support a model in which DED interaction
with stable microtubule structures arrests proliferation and induces
differentiation.
DED Microtubule Binding Is Required for Cell Cycle Arrest
and Differentiation
Caspase-8 DEDs contain a microtubule-association motif
(KLD) present in the second DED (DEDb) [14]. The motif is
required for caspase-8 localization to centrosomes, microtubules,
spindle poles and midbodies (Figure S2A)[14]. To test whether this
microtubule binding function was required for the differentiation
and anti-proliferative function of the DEDs, we next evaluated the
proliferative capacity of NB7 cells expressing a mutant caspase-8
DED construct (K156R) that selectively lacks microtubule
association, but still associates with other DED-containing proteins
[14]. In contrast to neuroblastoma expressing wildtype DEDs,
those expressing the K156R mutant were unaffected by
DEDK156R expression. These cells did not differentiate, and
proliferated similar to untransfected controls with no increased
incidence of mitotic defects (Figure 5A and B). Accordingly, in
tumors grown in the chick CAM, the DEDK156R cells grew
similar to those expressing GFP (Figure 5C), while the expression
of DEDs arrested growth, with a corresponding decrease in cell
proliferation (Figure 5D). These results demonstrate that micro-
tubule association is critical for DED-mediated differentiation and
arrest of proliferation. Together, these data reveal a new role for
caspase-8 DEDs in the regulation of cell differentiation and
senescence.
Discussion
In this study, we characterize a new function for the death
effector domains of caspase-8 in cell cycle regulation. First, we find
that caspase-8 DEDs accumulate in cells undergoing terminal
differentiation. Silencing of caspase-8 disrupts or delays differen-
tiation, while reintroduction of DEDs restores differentiation
potential. We further report that DED expression is sufficient to
impair tumor growth and cell proliferation, promoting mitotic
defects that foster cell death or cell cycle arrest and terminal
differentiation. Finally, we demonstrate that these events require a
critical lysine (K156) in a microtubule binding motif in the second
DED (DED-b). These observations together suggest that caspase-8
DEDs function as a tumor suppressor, acting as an anti-
proliferation and differentiation-inducing element. It is tempting
to speculate that this type of mechanism may act in some
spontaneously regressing tumors, such as stage IV-S neuroblasto-
ma, however, such a mechanism would be co-dependent upon
other classic tumor suppression pathways, including p53 and p21.
Interestingly, the cell lines which can maintain higher levels of
DEDs, such as COS-7, also have documented defects in p53
signaling.
Reconstitution of DED expression in the caspase-8 deficient
NB7 cells similarly leads to an increase in multi-nucleation. This
effect resembles the effect of microtubule-directed agents which
disrupt mitotic spindle formation and chromosome segregation.
However, these microtubule disrupting agents do not efficiently
induce differentiation, suggesting that the DEDs may play
additional roles following microtubule binding. Collaborative
effect is observed between caspase-8 DEDs and microtubule
stabilizing agents, but not microtubule-disrupting drugs [14]. It is
Figure 4. Caspase-8 DEDs activate p53, p21 and trigger
apoptosis or cell cycle arrest. A. Bright field images of NB7
neuroblastoma cells expressing DED-GFP at passages 8 (early) and 30
(late) (scale bar=10 mm). At earlier passages, a few multinucleated DED-
expressing cells are detectable (yellow arrows). By passage 30, DED-GFP
cells show high numbers of elongated or apoptotic cells. Late passage
cells were stained with propidium iodide and assessed by flow
cytometry to quantitate the sub-G1 apoptotic population at passage
30. B. Confocal microscopy confirmed the increase in nuclear
expression of p21 and p53 (two markers of cell cycle arrest) and the
cytoplasmic upregulation of the neuronal differentiation marker MAP2
in DED-GFP cells at passage 25 (scale bar=10 mm). White arrows show
nuclear accumulation of p21 and p53 (red channel).
doi:10.1371/journal.pone.0007879.g004
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increase DED association with microtubules [14].
Death domain proteins are a large and evolutionarily ancient
family. Defined by Tube and Pelle, each domain consists of six
peptide helices, with the specific homology placing family
members into subfamilies that include the DEDs, the classic death
domain (DD) proteins, the pyrin domains proteins, and the
caspase recruitment domain (CARD) families [31]. Interactions
among these proteins are frequently homotypic or within a
subfamily, but interactions between different families, and with
unrelated proteins, are unknown. Microtubules have several
surface helices with which microtubule-binding proteins interact,
as well as cell surface clefts bound by KLD/KID-containing
proteins such as kinesins, Tau, and MAP2C [32,33]. While other
DED proteins lack the KLD motif in the turn between helix 4 and
5 of the DED structure, it remains possible that some might still
associate with microtubules. For example, at least one death
domain protein with a CARD fold, CARD6, interacts with
microtubules [34].
It is also possible that DED-mediated effects can influence
differentiation or proliferation arrest among cells in which the
apoptotic pathway is compromised. For example, it is common for
tumor cells to express high levels of anti-apoptotic proteins that
interrupt the catalytic cascade [35], or which otherwise alter the
threshold of caspase-8 activation required for apoptosis [36,37].
Alternatively, low level activation of caspase-8 may contribute to
aberrant cell growth, since activation of the extrinsic death
pathway at levels which do not induce apoptosis can foster NF-kB
signaling [38]. Since caspase-8 maturation occurs concomitant
with the accumulation of DEDs, DED accumulation may act to
oppose NF-kB signaling, functioning as a tumor suppressor via
their microtubule-associated function. Given the caveats of the
studies performed here, it would appear that the DEDs have a
better stability than the catalytic domain, which is a target of
RING protein-mediated clearance [37].
In summary, we describe a novel function for caspase-8 as an
orchestrator of not only apoptosis but also differentiation and
senescence. The function is unexpectedly associated with the
Figure 5. DED binding to microtubules and centrosomes via Lysine 156 is required for cell cycle arrest. A. The proliferation capacity of
NB7-GFP, NB7 DED-GFP and NB7 DEDK156R-GFP was monitored by direct counting of cells after 24, 48 and 72 hours in culture after being seeded at
100 000 cells/ml. Values are given for one experiment representative of three. Confocal microscopy images show the localization of wildtype DED-
GFP at microtubules and centrosomes and the cytoplasmic localization of the DEDK156R-GFP mutant (Insets). B. Quantification of multinucleated
NB7 GFP, NB7 DED-GFP and NB7 DEDK156R-GFP cells. C. Tumor mass (wet weight) of tumors harvested from the chorioallantoic membrane of chicks
Tumors were seeded at passage 15. The mass of the tumor cells at seeding was 40 mg. D. The relative proliferation of the tumors, assessed by Ki-67
expression within tumor sections, was assessed by immunofluorescence. The fluorescent pixels per low power field field is shown. Data were
analyzed with T-student Test (*, significant differences, p#0.05; ** p#0.01).
doi:10.1371/journal.pone.0007879.g005
C8-DEDs Induce Differentiation
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7879amino-terminal death effector domains, and does not require
caspase-8 catalytic activity. The ermerging roles of this multifunc-
tional protein, and its surprising interactions at the nexus of the
cellular migration, proliferation, differentiation and apoptosis
pathways, continue to offer key insights into the signaling cross-
talk that regulates cell fate.
Methods
Cell Culture and Differentiation
Human leukemic cell line U937 (CRL-1593.2, American Tissue
Culture Collection, Rockville, MD) were grown in RPMI 1640
medium with glutamax-I (Gibco, Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum (HyClone, Logan,
UT) under standard cell culture conditions.
Differentiation was induced by culturing cells in the presence of
20 nM Phorbol 12-myristate 13-acetate (Sigma-Aldrich, St. Louis,
MO) during indicated time.
After treatment, transmission light pictures were taken with an
inverted Microscope (Eclipse, Nikon Inc, USA) using MetaMorph
software (Molecular Devices, Sunnyvale, CA). Adherent cells were
harvested by first incubating the cells with Versene, a non
enzymatic dissociation buffer (Gibco, Carlsbad, CA) for 5 min,
followed by collecting the cells using a cell scraper. Cellular
differentiation was quantified by flow cytometry. Briefly, cells were
resuspended in PBS + 5% FBS, human IgG (1:100) was added and
cells were incubated on ice during 45 min to block unspecific
binding. Cells were stained using an anti human CD11b-APC
antibody (M1/70, Miltenyi Biotech Auburn, CA).
Viability Cell Cycle Analysis
Cell viability was analyzed by flow cytometry following
propidium iodide (PI) staining, essentially as described before
[34]. Briefly, cells were cultured for 48 hours and harvested,
resuspended in ice cold PBS containing 10 mg/ml of Propidium
iodide (PI) and analyzed by flow cytometry. The extent of
apoptosis was determined by plotting PI fluorescence versus the
forward scatter parameter, using the Cell Quest program. For
DNA content analysis (cell cycle distribution), cells were previously
permeabilized in methanol at 220uC, for 15 minutes and
resuspended in PBS containing RNase A and 10 mg/ml of PI.
Samples containing roughly 2610
4 cells were analyzed using the
Cell Quest program.
Immunoprecipitation and Immunoblotting
Cells were lysed in either NP40 lysis buffer (150 mM NaCl, 50
mM Tris Base pH 7.4, 1% NP40) or RIPA buffer (50 mM Tris
pH 7.4, 100 mM NaCl, 0.1% SDS) supplemented with complete
protease inhibitor mixture (Roche), 50 mM NaF and 1 mM
Na3VO4 and centrifuged at 13,000 g for 10 min at 4uC. Protein
concentration was determined by BCA assay. For immunoprecip-
itation, 500 mg of protein was incubated with 2 mg of rabbit anti-
GFP antibody (Abcam) overnight, at 4uC. Complexes were
precipitated with 25 ml of protein A/G (Pierce). Beads were
washed five times, eluted in boiling Laemmli buffer, resolved on
10% SDS-PAGE and immunoblotting was performed with mouse
anti-alpha tubulin antibody (1:1000). For immunoblot analysis,
30 mg of protein was boiled in Laemmli buffer and resolved on
10% gel.
Cell Culture and Transfections
Human neuroblastoma cells (NB7), deficient in caspase-8 were
cultured in RPMI supplemented with 10% fetal bovine serum,
glutamine and non-essential aminoacids. Human keratinocytes
(HaCat), human epithelial cells (A549) and monkey fibroblasts
(COS-7), were cultured in DMEM, supplemented as previously
described. Human endothelial cells (HUVECs) were cultured in
M199 with endothelial cell supplement, 10% fetal bovine serum,
glutamine and minimal essential aminoacids. NB7 cells deficient in
caspase-8 were transfected using the Fugene reagent following
manufacturer’s protocol. Stable cell lines were selected with
500 mg/ml G418 (Gibco) and sorted by Flow cytometry for GFP
positive cells. Caspase-8 expression was confirmed by immuno-
blotting with caspase-8 N-terminus (BD Pharmingen) and
C-terminus antibodies (hybridomas, clones C5 and C15, were a
gift from M. Peter, University of Chicago, USA). To create
caspase-8 deficient and control cell lines, U937 and HUVECs cells
were infected with lentivirus encoding shRNA to caspase-8 (Open
Biosystems) or a control shRNA as described previously (Wrasidlo
et al., 2008).
Vectors and Constructs
DNA for caspase-8 was kindly provided by Guy Salvesen,
Burnham Institute, La Jolla, USA. Full length caspase-8-GFP (C8-
GFP) and inactive mutant C360A (C8*-GFP) fusion proteins were
cloned into C1pEGFP (Clontech Laboratories). Death effector
domain from caspase-8 (DED-GFP), DED1-GFP and DED2-GFP
fusion proteins were generated using 59 and 39 primers containing
unique HindIII and BamHI restriction sites respectively, and
cloned into N2pEGFP. K156R, S109A and D135A mutations
were introduced in DED using the QuikChange Mutagenesis kit
(Stratagene) with appropriate mutagenesis primers. DED myc-His
fusion protein was made with the same primers but cloned into
pcDNA3.1 myc-His (Invitrogen).
Tumor Growth
For avian tumor studies, 5610
6 neuroblastoma cells suspended
in 40 ml of complete medium were seeded on 11-day-old chick
chorioallantoic membrane [35]. Tumors were left to develop for 7
days and were then resected and weighed.
Immunocytochemistry, Immunohistochemistry and
Confocal Microscopy
Cells were permitted to attach to coverslips, fixed with 4% PFA
and permeabilized in PBS containing 0.1% triton for three
minutes, blocked for 60 minutes, at room temperature with 2%
BSA in PBS. Cell were stained with monoclonal antibody to
amino terminus death effector domain of caspase-8 (Pharmingen
and Calbiochem), p53 (Cell signaling), p21 (Santa Cruz) polyclonal
antibody specific for alpha tubulin (Abcam), gamma tubulin
(Abcam), pericentrin (Abcam) or lamin B (Santa Cruz). All
primary antibodies were used at 1:100 dilution, for two hours at
room temperature. After washing several times with PBS, cells
were stained for two hours at room temperature, with secondary
antibody fluorescently labelled in green or red, specific for mouse,
rabbit or goat (Invitrogen) and diluted 1:300. In some cases, cells
were co-incubated with the blue DNA dye TO-PRO-3 (1:1000)
(Invitrogen).
Mouse skin isolated from P1 and P10 wildtype and knockout
animals were frozen in OCT (Tissue-Tek). Caspase-8, a tubulin
and epidermal differentiation markers, K5, K1 and loricrin were
stained in 8 mm frozen sections after tissues were fixed for 10 min
in cold acetone or cold acetone/methanol (for a tubulin staining).
For nuclear staining, TO-PRO-3 (invitrogen) was added to the
secondary antibody dilution. Immunofluorescence was detected
using Alexa-fluor 488 and Alexa-fluor 568 secondary antibodies
(Invitrogen). Samples were mounted in Vectashield hard set
C8-DEDs Induce Differentiation
PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7879mounting media (Vector Laboratories) and imaged on a Nikon
Eclipse C1 confocal microscope.
Supporting Information
Figure S1 Expression of caspase-8 DEDs in the differentiated
layers of the epidermis. A. Immunohistochemistry experiments
performed in mouse skin confirm expression of caspase-8 DEDs
(green channel) in the differentiated layers of the skin (spinous,
granular and cornified layers). The basal layer is stained in red
with keratin 5 and nuclei of keratinocytes are stained with TO-
PRO-3 (blue channel). Insets show magnified views of the skin. B.
Immunohistochemistry experiments performed in sequential
sections of mouse skin confirm expression of caspase-8 DEDs
(green channel) in the differentiated layers of the skin (spinous,
granular and cornified layers). The spinous and granular layers are
stained in red with keratin 1 and loricrin, respectively, and nuclei
of keratinocytes are stained in blue.
Found at: doi:10.1371/journal.pone.0007879.s001 (5.29 MB TIF)
Figure S2 Assessment of the localization of the DEDs from
c-FLIP. The DEDs of c-FLIP and caspase-8 can bind several
common targets. The distribution of GFP-fusion proteins
containing the amino-terminal DEDs of c-FLIP and caspase-8B
were compared. A. An alignment of the amino terminal region of
caspase-8, containing the DEDs of caspase-8 and c-FLIP, is
shown. The RxDLL motif (red) and a KLD motif (green) are
shown. B. Immunofluorescence imaging of DED-GFP fusion
protein localization (green channel) within NB7 cells. Nuclei are
stained with TO-PRO (blue channel) and microtubules with anti-a
tubulin (red channel) (Bar, 10 mm).
Found at: doi:10.1371/journal.pone.0007879.s002 (14.21 MB
TIF)
Figure S3 Endogenous DEDs associate with microtubules,
centrosomes, spindle poles and midbodies and accumulate in
multinucleated cells. A. Confocal microscopy images of COS-7,
HeLa, HaCat and NB16 cells showing localization of caspase 8
DEDs (green channel) at the microtubules, centrosomes, spindle
poles and midbody (red channel). Microtubules and midbodies are
stained with {small case alpha}-tubulin, centrosomes and spindle
poles are stained with anti-c-Tubulin (red channel), the DEDs with
amino-terminal caspase-8 antibody (green channel), and DNA/
chromosomes with TO-PRO(blue channel). Centrosomes are
imaged using a minimal confocal pinhole and fluorescence
thresholding of 80% (scale bar=10 microns). B. GFP and DED-
GFP expressing cells were stained with propidium iodide and
percentage of multinucleated cells ($4N) was measured by flow
cytometry. C. Confocal images showing COS-7 giant multinucle-
ated cells (scale bar=10 m). Quantification of COS-7 and NB7
multinucleated cells. Immunoblot analysis showing expression of
endogenous caspase-8 DED in COS-7 cells (inset). Data were
analyzed with U-Mann-Whitney Test (significant differences,
*, p,0.05; **, p,0.01).
Found at: doi:10.1371/journal.pone.0007879.s003 (18.77 MB
TIF)
Figure S4 DEDs impair tumor growth, proliferation and trigger
defects in mitosis. A. Scheme of GFP-tagged caspase-8 derivatives,
which express either the DEDs alone, the catalytic domain active
or inactive (C360A), the holoenzyme (caspase-8B) active or
inactive (C360A). B. Immunoblot analysis showing expression of
GFP, caspase-8 inactive-GFP (C8*-GFP), caspase-8-GFP (C8-
GFP), catalytic domain-GFP (CAT-GFP), catalytic domain
inactive-GFP (CAT*-GFP) and DED-GFP. Upper panel: Western
blotting with a C8 DEDs-specific antibody. Middle panel: Western
blotting with a C8 Catalytic domain-specific antibody. Lower
panel: Western blot with a tubulin-specific antibody, used as
loading control. C. Proliferation assay performed with GFP, C8-
GFP, C8*-GFP, CAT-GFP, CAT*-GFP and DED-GFP express-
ing cells. D. GFP, C8-GFP and DED-GFP expressing cells were
stained with propidium iodide and percentage of apoptotic cells
was measured by flow cytometry. Data were analyzed with
U-Mann-Whitney Test (*, significant differences, p#0.05; **, very
significant differences, p#0.01). E. Evaluation of tumor growth in
chick embryos of NB7 neuroblastoma cells stably transfected with
DED-GFP, Casp8-GFP, Casp8*-GFP or control GFP. F.
Immunofluorescence images of human Small Cell Lung Carcino-
ma Cells (SCLC) transfected with DED-GFP or control GFP and
Neuroblastoma NB7 cells transfected with DED-GFP, stained
with lamin B (red channel) and a DNA dye (blue channel) show
accumulation of micronuclei. White arrows show micronuclei or
amorphous nuclei (scale bar=10 mm).
Found at: doi:10.1371/journal.pone.0007879.s004 (25.72 MB
TIF)
Figure S5 Implication of caspase-8 DEDs in cell differentiation
and senescence. A. Immunoblot analysis confirmed the increase of
the cell cycle arrest marker p21 and the neuronal differentiation
marker tubulin beta III in DED-GFP cells at passage 25.
Immunoblot analysis of actin is shown as loading control. B.
Bright field and confocal microscopy images of Human Umbilical
Vein Endothelial Cells (HUVECs) at early passages (up to P4) and
late passages (P6-P8). Nuclear p53 staining (red channel) confirms
accumulation of senescent cells at late passages. Lamin B staining
(red channel) shows accumulation of binucleated cells at late
passages (yellow arrows) (scale bar=10 mm). Immunoblot analysis
with a caspase-8 DEDs specific antibody on HUVECs shows
accumulation of DED at late passages. Immunoblot analysis of
tubulin is shown as loading control. Quantification of multinucle-
ated HUVECs at early and late passages. C. Quantification of
multinucleation in wild type and lentivirus encoding shRNA to
caspase-8 infected endothelial cells, at early and late passages.
Immunoblot analysis showing caspase-8 expression in these cells
(inset). Data were analyzed with U-Mann-Whitney Test (signifi-
cant differences, *, p#0.05; **, p#0.01).
Found at: doi:10.1371/journal.pone.0007879.s005 (21.02 MB
TIF)
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